Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
XP Inc. initiated with a Neutral at BTG Pactual » 08:13
01/27/20
01/27
08:13
01/27/20
08:13
XP

XP Inc.

$38.55 /

-2.47 (-6.02%)

BTG Pactual initiated…

BTG Pactual initiated coverage of XP Inc. with a Neutral rating and $37 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Thursday
Options
Ten new option listings and two option delistings on January 23rd » 08:30
01/23/20
01/23
08:30
01/23/20
08:30
AKRO

Akero Therapeutics

$23.34 /

+0.46 (+2.01%)

, AQST

Aquestive Therapeutics

$3.90 /

-0.2 (-4.88%)

, CYCN

Cyclerion Therapeutics

$3.75 /

+0.23 (+6.53%)

, ITRN

Ituran

$25.31 /

-0.51 (-1.98%)

, OBSV

ObsEva

$4.39 /

-0.09 (-2.01%)

, PHAS

PhaseBio

$5.43 /

-0.2 (-3.55%)

, PHAT

Phathom Pharmaceuticals

$38.10 /

+1.29 (+3.50%)

, STOK

Stoke Therapeutics

$23.87 /

+0.52 (+2.23%)

, XP

XP Inc.

$42.45 /

+1.845 (+4.54%)

, MDR

McDermott

$0.70 /

+ (+0.00%)

, TOO

Teekay Offshore Partners

$1.54 /

-0.005 (-0.32%)

New option listings for…

New option listings for January 23rd include Akero Therapeutics Inc (AKRO), Aquestive Therapeutics Inc (AQST), Cyclerion Therapeutics Inc (CYCN), Ituran (ITRN), McDermott International Inc (MDRIQ), ObsEva (OBSV), PhaseBio Pharmaceuticals Inc (PHAS), Phathom Pharmaceuticals Inc (PHAT), Stoke Therapeutics Inc (STOK), and XP Inc (Class A Stock) (XP). Option delistings effective January 23rd include McDermott International Inc (MDR) and Teekay Offshore Partners LP (Units) (TOO).

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
Initiation
Morgan Stanley starts XP Inc. at Overweight with $45 price target » 09:55
01/06/20
01/06
09:55
01/06/20
09:55
XP

XP Inc.

$37.41 /

-0.79 (-2.07%)

Morgan Stanley analyst…

Morgan Stanley analyst Jorge Kuri initiated coverage of XP Inc. with an Overweight rating and $45 price target, citing his view that the company is well positioned to capture strong industry growth and asset allocation shifts in Brazil given its "best-in-class" technology, superior open platform, leading IFA distribution network, brand name and execution. XP is the largest online broker in Brazil "by far" and it offers consumers a variety and depth of product and a level of advisory and service that the incumbent banks don't, Kuri tells investors.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
XP Inc. initiated with an Overweight at Morgan Stanley » 09:28
01/06/20
01/06
09:28
01/06/20
09:28
XP

XP Inc.

$38.20 /

-0.42 (-1.09%)

Morgan Stanley initiated…

Morgan Stanley initiated coverage of XP Inc. with an Overweight rating and $45 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
XP Inc. initiated with an Overweight at JPMorgan » 08:59
01/06/20
01/06
08:59
01/06/20
08:59
XP

XP Inc.

$38.20 /

-0.42 (-1.09%)

JPMorgan analyst Domingos…

JPMorgan analyst Domingos Falavina initiated coverage of XP Inc. with an Overweight rating and $44 price target. The company is "rapidly" growing as clients move away from traditional banks to independent investment advisors, Falavina tells investors in a research note. Hisanalysis indicates that XP offers the broadest range of investment alternatives to its clients at more competitive price.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
XP Inc. initiated with a Neutral at Goldman Sachs » 21:53
01/05/20
01/05
21:53
01/05/20
21:53
XP

XP Inc.

$38.20 /

-0.42 (-1.09%)

Goldman Sachs analyst…

Goldman Sachs analyst Tito Labarta initiated coverage of XP Inc. with a Neutral rating and $40 price target. The analyst thinks XP is "uniquely positioned" to gain share from the large banks in Brazil as an independent Brazilian financial advisor. However, he views the stock's current valuation as "rich."

Over a month ago
On The Fly
Opening Day: XP finishes first week higher, Sprout Social lower » 15:25
12/15/19
12/15
15:25
12/15/19
15:25
BILL

Bill.com

$38.59 /

+3.09 (+8.70%)

, EH

Ehang

$12.87 /

+0.39 (+3.13%)

, HCCO

Healthcare Merger Corp.

$0.00 /

+ (+0.00%)

, OCFT

OneConnect

$10.08 /

+ (+0.00%)

, SPT

Sprout Social

$16.76 /

+ (+0.00%)

, XP

XP Inc.

$37.61 /

+3.235 (+9.41%)

This past week saw six…

Open Full Text

Syndicate
XP opens at $32.75, IPO priced at $27.00 per share  11:41
12/11/19
12/11
11:41
12/11/19
11:41
XP

XP Inc.

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 11
    Dec
Syndicate
XP indicated to open at $32.50, IPO priced at $27.00  11:29
12/11/19
12/11
11:29
12/11/19
11:29
XP

XP Inc.

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 11
    Dec
Syndicate
XP indicated to open at $32.00, IPO priced at $27.00  10:53
12/11/19
12/11
10:53
12/11/19
10:53
XP

XP Inc.

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 11
    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.